Market Cap: $3.6793T -2.630%
Volume(24h): $210.1238B 27.900%
  • Market Cap: $3.6793T -2.630%
  • Volume(24h): $210.1238B 27.900%
  • Fear & Greed Index:
  • Market Cap: $3.6793T -2.630%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$113631.479686 USD

-2.00%

ethereum
ethereum

$3520.743224 USD

-5.26%

xrp
xrp

$2.975668 USD

-1.41%

tether
tether

$0.999590 USD

-0.04%

bnb
bnb

$765.480635 USD

-2.81%

solana
solana

$164.408416 USD

-4.17%

usd-coin
usd-coin

$0.999790 USD

-0.03%

tron
tron

$0.326752 USD

-0.10%

dogecoin
dogecoin

$0.201954 USD

-3.61%

cardano
cardano

$0.722537 USD

-2.09%

hyperliquid
hyperliquid

$38.070603 USD

-8.41%

sui
sui

$3.486261 USD

-3.77%

stellar
stellar

$0.386280 USD

-3.08%

chainlink
chainlink

$16.205186 USD

-4.34%

bitcoin-cash
bitcoin-cash

$540.533382 USD

-4.15%

Cryptocurrency News Articles

Rexas Finance (RXS) Could Outpace Cardano (ADA) by a Whopping 10x Margin in 2025

Mar 27, 2025 at 01:55 am

Like many other markets, the cryptocurrency market never stands still, with new projects emerging to compete with established networks.

Rexas Finance (RXS) Could Outpace Cardano (ADA) by a Whopping 10x Margin in 2025

Like many other markets, the cryptocurrency market never stands still, with new projects emerging to compete with established networks. Cardano (ADA), a well-known blockchain platform, has been a major player for several years. However, more recent AI-driven analyses from the Rexas Finance (RXS) project suggest they could surpass Cardano by a whopping 10x margin in 2025. With its rapidly selling presale, innovative tokenomics, real-world asset tokenization, expanding dApp ecosystem, and lucrative giveaway, Rexas Finance presents a compelling case for outpacing ADA. Here’s how RXS is positioned to achieve this ambitious milestone.

Presale Outpaces Cardano in Unprecedented Demand

The ongoing presale of Rexas Finance is a significant indicator of investor confidence. RXS is now at $0.20 during the final stage and will launch at $0.25. The project has managed to raise more than $47.2 million out of its $56 million goal, with over 91.20% of the tokens already sold. This indicates a healthy level of market interest, in stark contrast to Cardano’s struggles during its early development phases.

The project's website provides a useful visualization of the presale progress. As of press time, about $47.2 million has been raised out of a $56 million goal. A total of 1.1 billion RXS tokens will be sold during the presale, which is set to end on June 19, 2025.

At the beginning of the year, Cardano was touted as one of the most promising cryptocurrencies, especially among institutional investors. However, despite high expectations, Cardano failed to live up to the hype in 2024. The slow rollout and research-first approach hampered initial adoption, leading to limited interest from the broader market. In contrast, Rexas Finance takes a more dynamic and investor-friendly route.

By securing early adopters and ensuring token distribution before its official listing, Rexas Finance is setting the stage for a major market impact. The presale's overwhelming success signals that RXS could enter exchanges with even greater demand than ADA saw at similar stages in its development.

Tokenomics: A Structure Designed for Exponential Growth

Comparing the tokenomics of RXS and ADA sheds light on why analysts predict a 10x multiple of gains for Rexas Finance.

RXS has a total supply of 1 billion tokens, with strategic allocations that support stability and growth. The presale alone accounts for 42.5% of the total supply, ensuring widespread distribution. Liquidity receives 15% to maintain a healthy trading environment, and a 22.5% staking pool provides incentives for long-term holding. Finally, only 3% is allocated to the team, minimizing centralization risks and ensuring power remains with the community.

In comparison, Cardano has a much larger supply with a slower token distribution. While ADA's staking model is well-established, RXS introduces additional benefits through yield optimization in its treasury, offering more compelling incentives for investors.

| Token | Symbol | Total Supply | Presale | Liquidity | Staking | Team, Advisor, and Ecosystem

Development Service Account

Original source:crypto-reporter

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Aug 02, 2025